Umpqua Holdings Corp (NASDAQ:UMPQ) increased +0.51% during last trading as the stock added $0.08 to finish the day at $15.89 with about 952,105.00 shares changing hands, compared to its three month average trading volume of 1.87M. The $3.52B market cap company, which fluctuated between $15.73 and $15.91 during the day, currently situated 20.56% above its 52 week low of $13.18 and -9.20% away from its one year high of $17.50. The RSI of 57.12 indicates the stock is overbought at the current levels, sell for now. Umpqua Holdings Corporation is a financial holding company. The Company’s principal operating subsidiaries include Umpqua Bank (the Bank) and Umpqua Investments, Inc. (Umpqua Investments). It operates through two segments: Community Banking and Home Lending.
Extended Stay America Inc (NYSE:STAY) gained $0.13 to close the day at a new closing price of $14.44, a +0.91% increase in value from its previous closing price that moved the stock 41.95% above its 52 week low of $10.17. A total of 921,834.00 shares exchanged hands during the day compared with its three month average trading volume of 487,057.00. The stock, which fluctuated between $14.23 and $14.51 during the day, currently situated -22.68% below its 52 week high. The stock is down by -3.01% in the past one month and up by 8.18% over the past three months. With a one year target estimate of $17.65 and RSI of 52.38, the stock still has upside potential, making it a hold for now. Extended Stay America, Inc. (Extended Stay) is an integrated owner/operator of company-branded hotels in North America.
Cerus Corporation (NASDAQ:CERS) had a light trading with around 920,111.00 shares changing hands compared to its three month average trading volume of 1.35M. The stock traded between $6.57 and $6.81 before closing at the price of $6.76 with 0.90% change on the day. The company is currently trading 41.95% above its 52 week low of $10.17 and -22.68% below its 52 week high of $18.68. Both the RSI indicator and target price of 52.38 and $17.65 respectively, lead us to believe that it could drop over the coming weeks. Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment.